“…No recurrence in 5 years. Read and Williams, 2017 [15] | Cervicomedullary junction | Neck pain and rapid onset of arm and leg weakness | 5 years | 1,4 cm enhancing mass at cervicomedullary junction | WHO grade I | Systemic doxorubicin | n/a |
Sadiya et al , 2019 [16] | Left frontal | Slurred speech | 1 year | 2,9 × 2,5 × 2,4 cm solid cyctic tumor of left frontal dural base with invasion of brain parenchyma | WHO grade II-III | Subtotal resection and radiotherapy | n/a |
Shingai et al , 2021 [17] | Sphenoid | Intermittent diplopia | 7 years | Tumor mass in the posterior part of sphenoid with right oculomotor invasion | WHO grade II | Resection and gamma knife radiotherapy | n/a |
Thomas et al , 2019 [18] | Right middle fossa | Generalized tonic-clonic seizures | 7 years, 2 years, 5 years, and 2 years | 2,4 × 2,9 × 1,5 cm right middle fossa with foramen ovale invasion | WHO grade II | Surgical resection, bevacizumab and everolimus | n/a |
Wang et al , 2015 [19] | Right orbitofrontal | Serious Headache, Gradually impaired vision of the right eye, and vomiting | 3 years, 2 years, and 5 months | 1. Small local reccurence tumor 2. |
…”